The latest price target for PLDT (NYSE:PHI) was reported by UBS on August 27, 2025. The analyst firm set a price target for $0.00 expecting PHI to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for PLDT (NYSE:PHI) was provided by UBS, and PLDT downgraded their neutral rating.

There is no last upgrade for PLDT

The last downgrade for PLDT Inc happened on August 27, 2025 when UBS changed their price target from N/A to N/A for PLDT Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PLDT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PLDT was filed on August 27, 2025 so you should expect the next rating to be made available sometime around August 27, 2026.

While ratings are subjective and will change, the latest PLDT (PHI) rating was a downgraded with a price target of $0.00 to $0.00. The current price PLDT (PHI) is trading at is $21.95, which is out of the analyst’s predicted range.